Bring the product name into the appointment, not just the company name. BlueChew GOLD means sildenafil, tadalafil, apomorphine and oxytocin in a sublingual product. The useful opening question is how that exact prescription would fit your symptoms, previous treatment and other medicines. This review turns the public offer into a set of notes you can take to the clinician.
Use the corrected price example and the new strength table together when recording your quote. They describe offers; they do not select your prescription.
Availability: Public product listing; individual eligibility and current prescription require confirmation.
The exact product
Start by asking the prescriber to read back the active ingredients and dosage form. Here the decision involves the rationale and evidence for four active ingredients. A familiar brand can offer several unrelated preparations; an account preference is not the prescription itself. Put the proposed medicine beside anything you already take, including intermittent treatments and supplements. If the names do not match what you expected, settle that discrepancy before interpreting a delivery or price promise.
| Provider | BlueChew |
|---|---|
| Listed active ingredients | Sildenafil + tadalafil + apomorphine + oxytocin |
| Dosage form | Compounded sublingual tablet |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | BlueChew: platform, care process, and safety information · BlueChew: GOLD product and plan information · BlueChew: GOLD published cost breakdown |
Price, supply and payment
Make two entries in your notes: the advertised figure and the amount that would actually leave your account. The public figure for BlueChew GOLD is Public price examples differ; confirm the selected offer. The table below keeps any verified supply details beside it. A starting price, unit price and monthly equivalent are different kinds of information. Ask about shipping, consultation charges, renewal and what happens to an unused supply if the clinician changes the treatment early.
| GOLD-specific article | High strength, 18 tablets per month: $18.28 per tablet with monthly delivery (about $329/month), or $11.65 per tablet with quarterly delivery. Price table |
|---|---|
| Different cost article | Approx. $75 for 6 monthly doses |
| Price conclusion | Conflicting public examples; no universal confirmed quote |
| Oxytocin study boundary | 29 healthy couples, intranasal route; not the GOLD combination |
What the research can support
One practical way to read research is to name what was tested. The relevant record here is single-ingredient apomorphine trials and intranasal oxytocin research, not a GOLD trial. The unresolved question is comparative benefit of the finished four-drug preparation. Those distinctions belong in the consultation because a study of an ingredient cannot silently become a promise about this package. Ask what alternatives the prescriber considered and which result would count as a useful improvement for your circumstances.
| Evidence boundary | single-ingredient apomorphine trials and intranasal oxytocin research, not a GOLD trial |
|---|---|
| Not established here | comparative benefit of the finished four-drug preparation |
| Clinical and regulatory references | FDA: Compounding and the FDA — questions and answers · DailyMed: Tadalafil prescribing information, including section 5.11 · FDA: Locate a state-licensed online pharmacy · Behnia et al. (2014): intranasal oxytocin in couples · Dula et al. (2001): sublingual apomorphine crossover trial · MedlinePlus: Sildenafil · MedlinePlus: Tadalafil |
Safety questions for the prescriber
Give safety questions their own place on the page. BlueChew GOLD should not be added to an existing ED medicine without the prescribing team's instructions. Disclose nitrates, recreational nitrites, riociguat and blood-pressure medicines, together with heart, kidney, liver and eye conditions. A checklist cannot approve a prescription; it helps prevent omissions during the conversation. The additional product-specific issue below deserves an explicit answer.
| Multiple PDE5 inhibitors | Standard tadalafil labeling advises against combining PDE5 inhibitors; individualized rationale and monitoring are needed. |
|---|---|
| Apomorphine | A separate active ingredient; a single-ingredient trial is not a trial of this combination. |
Availability and the actual prescription
Before arranging your routine around this offer, confirm that it is available to you. The research record says: Public product listing; individual eligibility and current prescription require confirmation. An older listing or safety document is useful evidence about a formulation but does not establish that a new patient can order it. Ask whether the state, account history, pharmacy or clinical assessment changes the options, and keep the exact name used in the reply.
Refills, changes and cancellation
Decide how to contact the clinical team before the first refill becomes a billing question. Record whether the medicine helped the problem you described, whether you followed its instructions, and what side effects occurred. For BlueChew GOLD, take this question to the next conversation: “What evidence supports the added ingredients for my specific concern?” A message about symptoms and a request to stop shipments are separate tasks. Keep the account confirmation as well as the clinician's treatment instructions.
| Hold choices | A one-order skip differs from an indefinite stop-until-return setting. |
|---|---|
| Cancellation notice | At least 24 hours before renewal in the published policy. |
| Clinical plan changes | Account FAQ requests 48 hours; changes do not affect an order already processing. |
| Returns | Prescription returns are not accepted. |
| Policy sources | BlueChew: account and subscription questions · BlueChew: returns and refunds policy |
Compare named products
Use the linked alternatives to compare one concrete feature at a time: active ingredients, dosage form, schedule or full payment. Do not choose the longest ingredient list or the smallest milligram number as a shortcut. If an earlier treatment disappointed you, describe what happened rather than requesting a stronger-sounding brand. A comparison is useful when it improves the question you ask, not when it substitutes for an assessment.
Questions to keep with the offer
Your appointment note can end with three blanks: the exact prescription, the total first payment, and the date or trigger for clinical follow-up. Leave an item unanswered when the public evidence does not settle it. That is more useful than copying a competitor's terms into the gaps. This is documentary research; we have not ordered BlueChew GOLD, tested its effects or evaluated the clinicians involved.
| Ask about this formula | What evidence supports the added ingredients for my specific concern? |
|---|---|
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Compare strength and payment
These company-listed quantities describe the offer, not a dosing recommendation. Strength table
The detailed table gives about $79 for six Base tablets monthly; the other article still gives about $75 for six GOLD doses. Confirm your selected offer. Detailed table; other article.
Does GOLD work better than regular BlueChew? The evidence reviewed here does not establish that comparison. The cited studies examine different preparations; we read their abstracts, not the full papers. Apomorphine abstract; oxytocin abstract.
Put the strength name, the monthly tablet allocation and the delivery interval on separate lines in your quote. Keep the dated article or offer alongside them. If one number appears inconsistent, ask the service to identify the exact row and plan rather than using a rounded unit price to reconstruct the charge.
Bring the resulting document to the prescribing conversation with the question you want answered. A clearer table can help you describe the offer accurately; it cannot decide whether the proposed combination belongs in your care.
| Base | Sildenafil 70 mg; tadalafil 18 mg; apomorphine 2 mg; oxytocin 160 IU. |
|---|---|
| High | Sildenafil 90 mg; tadalafil 22 mg; apomorphine 3 mg; oxytocin 200 IU. |
| Extra | Sildenafil 110 mg; tadalafil 22 mg; apomorphine 4 mg; oxytocin 240 IU. |
Back to all individual product reviews
Sources for this page
New source entries show the date of this update. Earlier records keep their original research history and access limits. Company pages document published offers; they are not our own tests of treatment or service quality. Company pages support descriptions of advertised offers, not independent claims of clinical quality.
- BlueChew: platform, care process, and safety informationProvider source; current featured product and service description
- BlueChew: GOLD product and plan informationProvider source; four-ingredient compounded formulation
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
- FDA: Locate a state-licensed online pharmacyGovernment pharmacy verification resource
- BlueChew: GOLD published cost breakdownProvider marketing article; approximate price examples, not a checkout quote
- BlueChew: account and subscription questionsProvider policy; plan changes, one-order skips, and indefinite holds
- BlueChew: shipping and delivery questionsProvider policy; destination availability, shipping, and renewal terms
- BlueChew: returns and refunds policyProvider policy; prescription returns and 24-hour cancellation notice
- Behnia et al. (2014): intranasal oxytocin in couplesPrimary study; 29 healthy couples, different route and population from GOLD, abstract reviewed via NCBI
- Dula et al. (2001): sublingual apomorphine crossover trialPrimary randomized trial; single-ingredient apomorphine, abstract reviewed via NCBI
- BlueChew: product-specific approximate costsProvider price examples; approximate and not necessarily consistent with other offer pages
- MedlinePlus: SildenafilDrug information; standard sildenafil products
- MedlinePlus: TadalafilDrug information; standard tadalafil products
- GOLD pricesProvider article · Checked 2026-11-07